Results 201 to 210 of about 589,918 (307)
BJU International, Volume 137, Issue 2, Page 390-398, February 2026.Background Neurogenic bladder is defined as a dysfunction of the bladder resulting from damage to the central or peripheral nervous systems. Its treatment is based on a progressive therapeutic escalation, rapidly involving invasive therapeutic procedures such as repeated intradetrusor injections and surgery.
Marie Buzzi +6 more
wiley +1 more source
BJU International, Volume 137, Issue 2, Page 360-367, February 2026.Objectives To develop a drug‐releasing intravesical floating technology (DRIFT) device for controlled sequential delivery of gemcitabine and docetaxel (Gem/Doce) to optimise the treatment of non‐muscle‐invasive bladder cancer (NMIBC) while enabling patient mobility and self‐removal, as sequential intravesical Gem/Doce has been increasingly utilised but
Ashley C. Rhodes +11 more
wiley +1 more source
Infection and Drug ResistanceEsmatullah Esmat,1 Ramin Saadaat,1 Noor Hassan Saedi,1 Ahmadullah Hakimi,1 Abdul Tawab Baryali,2 Abdul Jamil Rasooli,3 Sahar Noor,3 Maryam Ahmad,1 Ahmed Maseh Haidary1 1Department of Pathology and Clinical Laboratory, French Medical Institute for Mother ...
Esmat E +8 more
doaj
A national pilot community pharmacy-led urinary tract infection service: clinical and patient-reported outcomes from 9077 consultations. [PDF]
J Antimicrob ChemotherMantzourani E +7 more
europepmc +1 more source
Ninety‐Day Readmission and Morbidity Following Liver Transplantation for MASLD
Clinical Transplantation, Volume 40, Issue 2, February 2026.ABSTRACT Introduction The incidence of short‐term (90‐day) hospital readmission and morbidity following liver transplantation (LT) for metabolic dysfunction‐associated steatotic liver disease (MASLD) is poorly characterized, and no study to date has distinguished these short‐term outcomes between MASLD and non‐MASLD LT recipients. The primary objective
Zachary Leslie +8 more
wiley +1 more source